Dr. Barry Dworkin

A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.

Medical Mythbusting Commentary for August 10, 2022

[display_podcast]

Source:
A vaccine for Lyme disease is in its final clinical trial

Related posts:

  1. HIV vaccine hopes should not be “dashed” by trial failure. Results contribute to understanding and formulating new approaches. We learn from our mistakes and failures in order to attain our goals.
  2. Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings.
  3. The development of mRNA vaccine technology has the potential to expand to treat and prevent other diseases akin to the technological spinoffs seen with the Apollo space program.
  4. Retrospective study finds that the flu vaccine has benefits against severe effects of COVID-19. How it does this remains unknown but if true, it will be fascinating and enlightening to figure out how our immune response works in this setting.